Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Global Human Micobiome 2016 Market Research Report

  • QYR678435
  • 153 Pages
  • September 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Global Human Micobiome 2016 Market Research Report is a professional and in-depth study on the current state of the Human Micobiome industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Micobiome market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.

The report focuses on global major leading industry players providing information such as company profiles, product research status and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Human Micobiome industry development trends and marketing channels are analyzed.

With 195 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview of Human Micobiome 1

1.1 Definition of Human Micobiome 1

1.1.1 Definition of Human Micobiome 1

1.2 Classification of Human Micobiome 2

1.2.1 Gastrointestinal Tract Human Micobiome 3

1.2.2 Urogenital Tract Human Micobiome 3

1.3 Applications of Human Micobiome 4

1.3.1 Treatment 5

1.3.2 Diagnosis 5

1.4 Industry Chain Structure of Human Micobiome 6

1.5 Industry Overview and Major Regions Status of Human Micobiome 7

1.5.1 Industry Overview of Human Micobiome 7

1.5.2 Global Major Regions Status of Human Micobiome 8

1.6 Industry Policy Analysis of Human Micobiome 8

1.7 Industry News Analysis of Human Micobiome 9

2 Manufacturing Cost Structure Analysis of Human Micobiome 14

2.1 Raw Material Suppliers and Price Analysis of Human Micobiome 14

2.2 Equipment Suppliers and Price Analysis of Human Micobiome 15

2.3 Labor Cost Analysis of Human Micobiome 18

2.4 Other Costs Analysis of Human Micobiome 21

2.5 Manufacturing Cost Structure Analysis of Human Micobiome 22

2.6 Manufacturing Process Analysis of Human Micobiome 23

3 Technical Data and R&D Status Analysis of Human Micobiome 24

3.1 R&D Date of Global Key Manufacturers 24

3.2 Accumulated Investment of Global Key Human Micobiome Manufacturers in 2011-2015 24

3.3 R&D Status and Technology Source of Global Human Micobiome Major Manufacturers in 2015 25

4 Investment Analysis of Human Micobiome by Regions, Types and Manufacturers 26

4.1 Global Investment of Human Micobiome by Regions 2011-2016 26

4.2 Global and Major Regions Investment and Growth Rate of Human Micobiome 2011-2016 29

4.3 Global Investment of Human Micobiome by Types 2011-2016 30

4.4 Global Investment of Human Micobiome by Manufacturers 2011-2016 33

5 Investment and R&D Investment Analysis of Human Micobiome by Types and Manufacturers 40

5.1 Investment and R&D Investment Analysis of Human Micobiome by Types 2011-2016 40

5.2 Investment and R&D Investment Analysis of Human Micobiome by Manufacturers 2011-2016 42

6 Consumption Value Forecast of Human Micobiome by Regions, Types and Applications 48

6.1 Global Consumption Value Forecast of Human Micobiome by Regions 2018-2023 48

6.2 Global Consumption Value Forecast of Human Micobiome by Types 2018-2023 51

6.3 Global Consumption Value Forecast of Human Micobiome by Applications 2018-2023 55

7 Major Region Consumption forecast 59

7.1 Global Consumption and Growth Rate of Human Micobiome 2018-2023 59

7.2 United States Consumption and Growth Rate of Human Micobiome 2018-2023 60

7.3 Europe Consumption and Growth Rate of Human Micobiome 2018-2023 61

8 Major Manufacturers Analysis of Human Micobiome 62

8.1 Vedanta 62

8.1.1 Company Profile 62

8.1.2 Product Specifications 63

8.1.3 Investment and Investment of R&D 64

8.2 Seres?Therapeutics 65

8.2.1 Company Profile 65

8.2.2 Product Specifications 66

8.2.3 Investment and Investment of R&D 67

8.3 Second Genome 69

8.3.1 Company Profile 69

8.3.2 Product Specifications 70

8.3.3 Investment and Investment of R&D 71

8.4 Rebiotix 72

8.4.1 Company Profile 72

8.4.2 Product Specifications 73

8.4.3 Investment and Investment of R&D 74

8.5 ActoGeniX (Interxon) 74

8.5.1 Company Profile 74

8.5.2 Product Specifications 75

8.5.3 Investment and Investment of R&D 76

8.6 Enterome BioScience 77

8.6.1 Company Profile 77

8.6.2 Product Specifications 79

8.6.3 Investment and Investment of R&D 80

8.7 AvidBiotics 81

8.7.1 Company Profile 81

8.7.2 Product Specifications 82

8.7.3 Investment and Investment of R&D 83

8.8 4D Pharma Research Ltd 85

8.8.1 Company Profile 85

8.8.2 Product Specifications 86

8.8.3 Investment and Investment of R&D 86

8.9 Enterologics 88

8.9.1 Company Profile 88

8.9.2 Product Specifications 89

8.9.3 Investment and Investment of R&D 90

8.10 Metabogen 91

8.10.1 Company Profile 91

8.10.2 Product Specifications 92

8.10.3 Investment and Investment of R&D 92

8.11 Metabiomics 94

8.11.1 Company Profile 94

8.11.2 Product Specifications 95

8.11.3 Investment and Investment of R&D 96

8.12 Ritter Pharmaceuticals 98

8.12.1 Company Profile 98

8.12.2 Product Specifications 99

8.12.3 Investment and Investment of R&D 100

8.13 Osel 101

8.13.1 Company Profile 101

8.13.2 Product Specifications 102

8.13.3 Investment and Investment of R&D 103

8.14 Symberix 105

8.14.1 Company Profile 105

8.14.2 Product Specifications 106

8.14.3 Investment and Investment of R&D 107

8.15 Miomics 108

8.15.1 Company Profile 108

8.15.2 Product Specifications 109

8.15.3 Investment and Investment of R&D 110

8.16 Symbiotix Biotherapies 112

8.16.1 Company Profile 112

8.16.2 Product Specifications 113

8.16.3 Investment and Investment of R&D 114

8.17 MicroBiome Therapeutics LLC 115

8.17.1 Company Profile 115

8.17.2 Product Specifications 116

8.17.3 Investment and Investment of R&D 117

9 Marketing Trader or Distributor Analysis of Human Micobiome 119

9.1 Marketing Channels Status of Human Micobiome 119

9.2 Traditional medicine Traders or Distributors with Contact Information of Human Micobiome by Regions 119

10 Industry Chain Analysis of Human Micobiome 121

10.1 Upstream Major Raw Materials Suppliers Analysis of Human Micobiome 121

10.2 Upstream Major Equipment Suppliers Analysis of Human Micobiome 122

10.3 Downstream Major Consumers Analysis of Human Micobiome 123

11 Development Trend of Analysis of Human Micobiome 125

11.1 Investment Forecast of Human Micobiome by Regions 125

11.1.1 Global Investment of Human Micobiome by Regions 2016-2021 125

11.1.2 Global and Major Regions Investment and Growth Rate of Human Micobiome 2016-2021 128

11.2 Investment Forecast of Human Micobiome by Types a 130

12 New Project Investment Feasibility Analysis of Human Micobiome 134

12.1 New Project SWOT Analysis of Human Micobiome 134

13 Conclusion of the Global Human Micobiome 2016 Market Research Report 135

Table and Figure

Figure Picture of Human Micobiome 2

Table Classification of Human Micobiome 2

Figure Global Investment Market Share of Human Micobiome by Types in 2015 3

Figure Picture Related to Gastrointestinal Tract Human Micobiome 3

Figure Picture Related to Urogenital Tract Human Micobiome 3

Table Applications of Human Micobiome 4

Figure Global Consumption Value Market Share of Human Micobiome by Applications in 2018 4

Figure Treatment Examples (RP-G28 Product) 5

Figure Industry Chain Structure of Human Micobiome 6

Figure Global Human Micobiome Major Manufacturers Investment Market Share in 2015 7

Figure Global Major Regions Human Micobiome Investment Market Share in 2015 8

Table Industry Policy of Human Micobiome 8

Table Industry News List of Human Micobiome 9

Table Raw Material Suppliers Analysis 14

Figure 2011-2016 Price Analysis (USD/500ml) of Microbial broth 15

Table Equipment Suppliers Analysis 15

Figure Equipment Specification of Biomedical Refrigerators 17

Figure Biomedical Refrigerators Price (USD/Unit) 18

Figure Manufacturing Labor Costs in Select Provinces and Countries in 2014 19

Figure Average Manufacturing Cost Index in 2014 19

Table United States Average Hourly Wages (USD/H) in 2015 20

Figure Germany Labor Costs 2013-2015 20

Figure France Labor Costs 2013-2015 21

Table 2015 Global Electricity Price of Industry (USD/KW·h) by Country 21

Table Manufacturing Cost Structure Analysis of Human Micobiome in 2015 22

Figure Manufacturing Process Analysis of Human Micobiome 23

Table R&D Date of Global Human Micobiome Key Manufacturers 24

Table Accumulated Investment (K USD) of Global Key Human Micobiome Manufacturers in 2011-2015 24

Table R&D Status and Technology Source of Global Human Micobiome Major Manufacturers in 2015 25

Table Global Investment (K USD) of Human Micobiome by Regions 2011-2016 26

Figure Global Investment Market Share of Human Micobiome by Regions in 2011 26

Figure Global Investment Market Share of Human Micobiome by Regions in 2012 27

Figure Global Investment Market Share of Human Micobiome by Regions in 2013 27

Figure Global Investment Market Share of Human Micobiome by Regions in 2014 28

Figure Global Investment Market Share of Human Micobiome by Regions in 2015 28

Figure Global Investment (K USD) and Growth Rate of Human Micobiome 2011-2016 29

Figure United States Investment (K USD) and Growth Rate of Human Micobiome 2011-2016 29

Figure Europe Investment (K USD) and Growth Rate of Human Micobiome 2011-2016 30

Table Global Investment (K USD) of Human Micobiome by Types 2011-2016 30

Figure Global Investment Market Share of Human Micobiome by Types in 2011 31

Figure Global Investment Market Share of Human Micobiome by Types in 2012 31

Figure Global Investment Market Share of Human Micobiome by Types in 2013 32

Figure Global Investment Market Share of Human Micobiome by Types in 2014 32

Figure Global Investment Market Share of Human Micobiome by Types in 2015 33

Table Global and Major Manufacturers Investment (K USD) of Human Micobiome 2011-2016 33

Table Global Investment Market Share of Human Micobiome Major Manufacturers 2011-2016 34

Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2011 35

Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2012 36

Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2013 37

Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2014 38

Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2015 39

Table Investment (K USD) of Human Micobiome by Types 2011-2016 40

Figure Investment (K USD) of Human Micobiome by Types in 2015 40

Table Investment of R&D (K USD) of Human Micobiome by Types 2011-2016 41

Figure Investment of R&D (K USD) of Human Micobiome by Types in 2015 41

Table R&D (%) of Human Micobiome by Types 2011-2016 41

Figure R&D (%) of Human Micobiome by Types in 2015 42

Table Investment (K USD) of Human Micobiome by Manufacturers 2011-2016 42

Figure Investment (K USD) of Human Micobiome by Manufacturers in 2015 43

Table Investment of R&D (K USD) of Human Micobiome by Manufacturers 2011-2016 44

Figure Investment of R&D (K USD) of Human Micobiome by Manufacturers in 2015 45

Table R&D(%) of Human Micobiome by Manufacturers 2011-2016 46

Figure R&D(%) of Human Micobiome by Manufacturers in 2015 47

Table Global Consumption Value Forecast (M USD) of Human Micobiome by Regions 2018-2023 48

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2018 48

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2019 49

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2020 49

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2021 50

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2022 50

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2023 51

Table Global Consumption Value Forecast (M USD) of Human Micobiome by Types 2018-2023 51

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2018 52

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2019 52

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2020 53

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2021 53

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2022 54

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2023 54

Table Global Consumption Value Forecast (M USD) of Human Micobiome by Applications 2018-2023 55

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2018 55

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2019 56

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2020 56

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2021 57

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2022 57

Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2023 58

Figure Global Consumption (M USD) and Growth Rate of Human Micobiome 2018-2023 59

Figure United States Consumption (M USD) and Growth Rate of Human Micobiome 2018-2023 60

Figure Europe Consumption (M USD) and Growth Rate of Human Micobiome 2018-2023 61

Table Vedanta Information List 62

Table Brief introduction of Vedanta Product 63

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Vedanta 2011-2016 64

Figure Human Micobiome Investment (K USD) and Growth Rate of Vedanta 2011-2016 64

Figure Human Micobiome Investment (K USD) and Global Market Share of Vedanta 2011-2016 65

Table Seres?Therapeutics Information List 65

Table Brief introduction of Seres?Therapeutics Product 66

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Seres?Therapeutics 2011-2016 67

Figure Human Micobiome Investment (K USD) and Growth Rate of Seres?Therapeutics 2011-2016 68

Figure Human Micobiome Investment (K USD) and Global Market Share of Seres?Therapeutics 2011-2016 68

Table Second Genome Information List 69

Table Brief introduction of Second Genome Product 70

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Second Genome 2011-2016 71

Figure Human Micobiome Investment (K USD) and Growth Rate of Second Genome 2011-2016 71

Figure Human Micobiome Investment (K USD) and Global Market Share of Second Genome 2011-2016 72

Table Rebiotix Information List 72

Table Brief introduction of Rebiotix Product 73

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Rebiotix 2011-2016 74

Figure Human Micobiome Investment (K USD) and Growth Rate of Rebiotix 2011-2016 74

Figure Human Micobiome Investment (K USD) and Global Market Share of Rebiotix 2011-2016 74

Table ActoGeniX (Interxon) Information List 74

Table Brief introduction of ActoGeniX (Interxon) Product 75

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of ActoGeniX (Interxon) 2011-2016 76

Figure Human Micobiome Investment (K USD) and Growth Rate of ActoGeniX (Interxon) 2011-2016 76

Figure Human Micobiome Investment (K USD) and Global Market Share of ActoGeniX (Interxon) 2011-2016 77

Table Enterome BioScience Information List 77

Table Brief introduction of Enterome BioScience Product 79

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Enterome BioScience 2011-2016 80

Figure Human Micobiome Investment (K USD) and Growth Rate of Enterome BioScience 2011-2016 80

Figure Human Micobiome Investment (K USD) and Global Market Share of Enterome BioScience 2011-2016 81

Table AvidBiotics Information List 81

Table Brief introduction of AvidBiotics Product 82

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of AvidBiotics 2011-2016 83

Figure Human Micobiome Investment (K USD) and Growth Rate of AvidBiotics 2011-2016 84

Figure Human Micobiome Investment (K USD) and Global Market Share of AvidBiotics 2011-2016 84

Table 4D Pharma Research Ltd Information List 85

Table Brief introduction of 4D Pharma Research Ltd Product 86

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of 4D Pharma Research Ltd 2011-2016 86

Figure Human Micobiome Investment (K USD) and Growth Rate of 4D Pharma Research Ltd 2011-2016 87

Figure Human Micobiome Investment (K USD) and Global Market Share of 4D Pharma Research Ltd 2011-2016 87

Table Enterologics Information List 88

Table Brief introduction of Enterologics Product 89

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Enterologics 2011-2016 90

Figure Human Micobiome Investment (K USD) and Growth Rate of Enterologics 2011-2016 90

Figure Human Micobiome Investment (K USD) and Global Market Share of Enterologics 2011-2016 91

Table Metabogen Information List 91

Table Brief introduction of Metabogen Product 92

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Metabogen 2011-2016 92

Figure Human Micobiome Investment (K USD) and Growth Rate of Metabogen 2011-2016 93

Figure Human Micobiome Investment (K USD) and Global Market Share of Metabogen 2011-2016 94

Table Metabiomics Information List 94

Table Brief introduction of Metabiomics Product 95

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Metabiomics 2011-2016 96

Figure Human Micobiome Investment (K USD) and Growth Rate of Metabiomics 2011-2016 97

Figure Human Micobiome Investment (K USD) and Global Market Share of Metabiomics 2011-2016 97

Table Ritter Pharmaceuticals Information List 98

Table Brief introduction of Ritter Pharmaceuticals Product 99

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Ritter Pharmaceuticals 2011-2016 100

Figure Human Micobiome Investment (K USD) and Growth Rate of Ritter Pharmaceuticals 2011-2016 100

Figure Human Micobiome Investment (K USD) and Global Market Share of Ritter Pharmaceuticals 2011-2016 101

Table Osel Information List 101

Table Brief introduction of Osel Product 102

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Osel 2011-2016 103

Figure Human Micobiome Investment (K USD) and Growth Rate of Osel 2011-2016 104

Figure Human Micobiome Investment (K USD) and Global Market Share of Osel 2011-2016 104

Table Symberix Information List 105

Table Brief introduction of Symberix Product 106

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Symberix 2011-2016 107

Figure Human Micobiome Investment (K USD) and Growth Rate of Symberix 2011-2016 107

Figure Human Micobiome Investment (K USD) and Global Market Share of Symberix 2011-2016 108

Table Miomics Information List 108

Table Brief introduction of Miomics Product 109

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Miomics 2011-2016 110

Figure Human Micobiome Investment (K USD) and Growth Rate of Miomics 2011-2016 111

Figure Human Micobiome Investment (K USD) and Global Market Share of Miomics 2011-2016 111

Table Symbiotix Biotherapies Information List 112

Table Brief introduction of Symbiotix Biotherapies Product 113

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Symbiotix Biotherapies 2011-2016 114

Figure Human Micobiome Investment (K USD) and Growth Rate of Symbiotix Biotherapies 2011-2016 114

Figure Human Micobiome Investment (K USD) and Global Market Share of Symbiotix Biotherapies 2011-2016 115

Table MicroBiome Therapeutics LLC Information List 115

Table Brief introduction of MicroBiome Therapeutics LLC Product 116

Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of MicroBiome Therapeutics LLC 2011-2016 117

Figure Human Micobiome Investment (K USD) and Growth Rate of MicroBiome Therapeutics LLC 2011-2016 118

Figure Human Micobiome Investment (K USD) and Global Market Share of MicroBiome Therapeutics LLC 2011-2016 118

Table Marketing Channels of Human Micobiome 119

Table Traditional medicine Traders or Distributors with Contact Information of Human Micobiome by Regions 119

Table Major Raw Materials Suppliers with Contact Information of Human Micobiome 121

Table Major Equipment Suppliers with Contact Information of Human Micobiome 122

Table Major Consumers with Contact Information of Human Micobiome 123

Table Global Investment (K USD) of Human Micobiome by Regions 2016-2021 125

Figure Global Investment Market Share of Human Micobiome by Regions in 2016 125

Figure Global Investment Market Share of Human Micobiome by Regions in 2017 126

Figure Global Investment Market Share of Human Micobiome by Regions in 2018 126

Figure Global Investment Market Share of Human Micobiome by Regions in 2019 127

Figure Global Investment Market Share of Human Micobiome by Regions in 2020 127

Figure Global Investment Market Share of Human Micobiome by Regions in 2021 128

Figure Global Investment (K USD) and Growth Rate of Human Micobiome 2016-2021 128

Figure United States Investment (K USD) and Growth Rate of Human Micobiome 2016-2021 129

Figure Europe Investment (K USD) and Growth Rate of Human Micobiome 2016-2021 129

Table Global Investment (K USD) of Human Micobiome by Types 2016-2021 130

Figure Global Consumption Value Market Share of Human Micobiome by Types in 2016 130

Figure Global Consumption Value Market Share of Human Micobiome by Types in 2017 131

Figure Global Consumption Value Market Share of Human Micobiome by Types in 2018 131

Figure Global Consumption Value Market Share of Human Micobiome by Types in 2019 132

Figure Global Consumption Value Market Share of Human Micobiome by Types in 2020 132

Figure Global Consumption Value Market Share of Human Micobiome by Types in 2021 133

Table New Project SWOT Analysis of Human Micobiome 134

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750